About SR One

our focus

SR One invests globally in early stage healthcare companies pursuing innovative, breakthrough science. Our expanded remit also focuses on accessing technology innovations from throughout GSK to create new value by using these inventions for other products and in other industries. Overall, we look for investments that can provide attractive financial returns and significant strategic value.

our team

We have a team of investment professionals located in the US and Europe. We understand the challenges facing emerging companies. Together, we bring practical industry expertise, an operational orientation and long-term perspective, from the beginning of the investment process through all aspects of value creation. Our investment record and focus on returns align us with financial investors and our industry perspective positions us to work effectively with company management teams.

how we work

We lead investments and work with other financial or strategic investors to syndicate our deals. We will also actively participate in opportunities as part of a syndicate. We are aligned with other financial investors and do not ask for specific product rights or options. We are active investors and typically take board of directors or board observer seats. We also maintain a strict firewall with GSK on confidential items received from a portfolio company or an investment opportunity under review by our team.

our investments

  • Establish and nourish investments in a portfolio of cutting edge, early-stage companies based on differentiation and innovation
  • Build a portfolio of incubator companies based on GSK technology platforms and know-how

Next
 
Aileron    Alios    Locus Pharmaceuticals